Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Clinical trial NCT00813124 · COMPLETED

Trial details

NCT number: NCT00813124
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stem Cell Transplantation Leukemia

Start date: 2008-12-01
Primary completion: 2014-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.